Overview

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

This is a Phase III, multicenter, randomized, placebo-controlled trial designed to evaluate the efficacy and safety of bevacizumab in combination with chemotherapy compared with chemotherapy alone in subjects with previously untreated metastatic breast cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Bevacizumab
Capecitabine